Attard, G;
Antonarakis, ES;
(2016)
Prostate cancer: AR aberrations and resistance to abiraterone or enzalutamide.
Nature Reviews Urology
, 13
(12)
pp. 697-698.
10.1038/nrurol.2016.212.
Preview |
Text
Attard_Antonarakis edited version_ed.pdf - Accepted Version Download (550kB) | Preview |
| Type: | Article |
|---|---|
| Title: | Prostate cancer: AR aberrations and resistance to abiraterone or enzalutamide |
| Location: | England |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1038/nrurol.2016.212 |
| Publisher version: | https://doi.org/10.1038/nrurol.2016.212 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | Androstenes, Antineoplastic Agents, Drug Resistance, Neoplasm, Humans, Male, Phenylthiohydantoin, Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant, Receptors, Androgen |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Oncology |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10067212 |
Downloads since deposit
170Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months
Archive Staff Only
 |
View Item |
